Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Elecom Co ( (JP:6750) ) has shared an announcement.
Elecom Co., Ltd. has announced planned changes to its corporate officer lineup, including the reappointment of eight existing directors and the elevation of Executive Officer Kota Hada to the board, subject to shareholder approval at the June 26, 2026 general meeting. Hada, who has a background as a physician and leads ELECOM Healthcare Co., Ltd., brings additional healthcare expertise into the core management structure, signaling continued emphasis on the company’s healthcare business alongside its core electronics operations.
The company has also nominated certified public accountant and tax accountant Yutaka Masuda as an alternate Audit and Supervisory Board member, drawing on his long experience at EY ShinNihon and in private practice. The move is expected to strengthen Elecom’s governance and oversight framework, supporting its strategic expansion and potentially reassuring investors and other stakeholders about the robustness of its audit and supervisory functions.
The most recent analyst rating on (JP:6750) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Elecom Co stock, see the JP:6750 Stock Forecast page.
More about Elecom Co
Elecom Co., Ltd. is a Japan-based manufacturer listed on the TSE Prime that develops and sells consumer and professional electronics-related products and peripherals. The company has been expanding into healthcare-related solutions through its subsidiary ELECOM Healthcare Co., Ltd., reflecting a strategic interest in the digital health and medical devices space.
Average Trading Volume: 190,801
Technical Sentiment Signal: Buy
Current Market Cap: Yen147.3B
See more insights into 6750 stock on TipRanks’ Stock Analysis page.